Effect of Ergocalciferol on Iron Metabolism in Individuals With Chronic Kidney Disease

NCT03073369 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study didn't materialize for various reasons.

Conditions

CKD
Chronic Kidney Diseases
Hepcidin
Ergocalciferol
Vitamin D
Iron-deficiency
Anemia

Interventions

DRUG: Ergocalciferol 50000 UNT
DRUG: Placebo

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]